Status: Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.
Participants needed: 9,999
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: New York Blood CenterUpdated: Apr 13, 2026Locations: 71
Eligibility criteria
Diagnosis: Patients with disorders affecting the hematopoietic system that are i... [+2]
Patients who are receiving licensed cord blood products (only) [+3]